These studies have provided mixed evidence, with most showing increased expression of ghrelin in neoplasms and potential indications of a carcinogenic role, while other studies demonstrated reduced ghrelin expression in tumors and/or a possible antineoplastic effect (Chopin et al. 2012). This evidence concerns the gene GHRL and neoplasm.